Pharmacological inhibition of leukotrienes in an animal model of bleomycin-induced acute lung injury.
about
Cyclooxygenase-2 deficiency exacerbates bleomycin-induced lung dysfunction but not fibrosisCysteinyl leukotrienes are autocrine and paracrine regulators of fibrocyte function.Macrophages and tissue injury: agents of defense or destruction?Serine/threonine kinase-protein kinase B and extracellular signal-regulated kinase regulate ventilator-induced pulmonary fibrosis after bleomycin-induced acute lung injury: a prospective, controlled animal experiment.Eicosanoid lipid mediators in fibrotic lung diseases: ready for prime time?Current and emerging drugs for idiopathic pulmonary fibrosis.Functional genomic assessment of phosgene-induced acute lung injury in mice.Investigational approaches to therapies for idiopathic pulmonary fibrosis.Emerging therapeutic interventions for idiopathic pulmonary fibrosis.BLT1 Mediates Bleomycin-Induced Lung Fibrosis Independently of Neutrophils and CD4+ T Cells.Neutrophil swarming toward Cryptococcus neoformans is mediated by complement and leukotriene B4.Preventive and therapeutic effects of thymosin β4 N-terminal fragment Ac-SDKP in the bleomycin model of pulmonary fibrosis.Effects of zileuton and montelukast in mouse experimental spinal cord injury.Involvement of leukotrienes in the pathogenesis of silica-induced pulmonary fibrosis in mice.Leukotriene C4 aggravates bleomycin-induced pulmonary fibrosis in mice.The arachidonate 5-lipoxygenase activating protein gene polymorphism is associated with the risk of scleroderma-related interstitial lung disease: a multicentre European Scleroderma Trials and Research group (EUSTAR) study.
P2860
Q36013692-F65A29A1-4592-4695-8641-A0CEFB7D1084Q36822323-6ED8698B-6FBE-4332-9C3E-B733D6BAF2DBQ36896804-9732DB35-2F70-4623-A2FC-98616A5726B2Q36955268-43D63A97-3775-4BA3-A647-08DA5656583EQ36970702-A5BC1629-D645-4A18-B8FD-754F0F0D7226Q36989934-87A5409F-4510-4857-92AA-26EE4A7F0FABQ37297966-B89F9EAC-8E56-4FD4-811C-493255D4BED0Q37742646-B48B4A2D-E979-4EE4-A7A6-2642EA818E2EQ38207153-409D7FA9-23F4-4306-82F5-52F1479235DFQ40385076-1389030D-8D0F-4D3F-97DD-EC02B6AEF048Q40617677-CABC7F22-ED6D-42EA-9E93-19F452A2CFB2Q41609962-F1B1130A-4710-4938-8D4A-994930FC19A9Q43042658-EF34787E-B7D8-49D5-911A-3E8C9BBAE62BQ43055697-71379295-E9AE-4866-803C-EE60ADFFFCA8Q46011006-D90F912A-F7F9-49FC-B8E1-5EF58E7CDD5EQ47981856-4819A7A6-0729-4C28-9E57-AF23939D7B08
P2860
Pharmacological inhibition of leukotrienes in an animal model of bleomycin-induced acute lung injury.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Pharmacological inhibition of ...... cin-induced acute lung injury.
@en
type
label
Pharmacological inhibition of ...... cin-induced acute lung injury.
@en
prefLabel
Pharmacological inhibition of ...... cin-induced acute lung injury.
@en
P2093
P2860
P50
P356
P1433
P1476
Pharmacological inhibition of ...... cin-induced acute lung injury.
@en
P2093
Achille P Caputi
Carlo Vancheri
Carmelo Muià
Elisa Gili
Marco Failla
Mariangela Sortino
Nunzio Crimi
P2860
P2888
P356
10.1186/1465-9921-7-137
P577
2006-11-21T00:00:00Z
P5875
P6179
1019485707